Skin lesion's treatment with alfa interferon in a patient with B-CLL

Simple item page
dc.contributor.authorPanteli, K.en
dc.contributor.authorKatsanos, K. H.en
dc.contributor.authorKitsanou, M.en
dc.contributor.authorNakou, K.en
dc.contributor.authorAlexandridis, G.en
dc.contributor.authorBourantas, K. L.en
dc.date.accessioned2015-11-24T18:51:17Z
dc.date.available2015-11-24T18:51:17Z
dc.identifier.issn0392-9078-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18236
dc.rightsDefault Licence-
dc.subjectAgeden
dc.subjectAntineoplastic Agents/*administration & dosageen
dc.subjectHumansen
dc.subjectInterferon-alpha/*administration & dosageen
dc.subjectLeukemia, Lymphocytic, Chronic, B-Cell/*drug therapy/pathology/physiopathologyen
dc.subjectMaleen
dc.subjectRecombinant Proteinsen
dc.subjectRemission Inductionen
dc.subjectSkin Neoplasms/*drug therapy/pathology/physiopathologyen
dc.titleSkin lesion's treatment with alfa interferon in a patient with B-CLLen
heal.abstractTreatment with recombinant alfa-2b-interferon in a patient with advanced B-CLL resulting in complete remission of skin lesions after one month therapy is reported in this paper. Interferon was administered subcutaneously three times weekly. Six months later while the treatment continued, the disease remained stable.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/10840947-
heal.journalNameJ Exp Clin Cancer Resen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2000-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Files

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.74 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ